Kazakh research institute: US$100 million to enact comprehensive plan to counter cancer mortality

According to screening data, Kazakhs suffer more often from breast, lung and colorectal cancer.
Kazakh research institute: US$100 million to enact comprehensive plan to counter cancer mortality
06 December 09:44 2018 Print This Article

The Kazakh Research Institute of Oncology and Radiology has prepared a 35 billion tenge (US$93.88 million) action plan to reduce cancer mortality rates for the next year, Director of the institute Dilyara Kaidarova.

The comprehensive plan to fight cancer includes the purchase of innovative equipment, some types of which are not yet available in the country.

The institute plans to update all radiotherapy technology in country’s regions, to allow doctors to use more modern methods. All patients will be able to receive treatment free of charge.

Some of the plan’s funds will be allocated to install equipment for proton therapy at Astana’s new oncology centre. The therapy is one of the most progressive and safest treatment methods. Surgeons use the method most often to treat cancers of the brain and cornea in children. According to Kaidarova, there are 57 such centres worldwide.

“Now, within our institute at Nazarbayev University, we are conducting a large scientific study on the identification of gene mutations that contribute to the development of cancer in the Kazakh population, because Kazakhs have certain types of cancer that are not the same as in Europeans or Americans,” she said.

Minister of Healthcare Yelzhan Birtanov said changes are also underway in the care system for patients with cancer.

“We are rebuilding the entire system of oncological care. Today, there is a gradual shift to early detection and diagnosis of cancer based on screening research and high-tech detection methods, including laboratory detection,” said Birtanov.

Print this entry

  Categories:
view more articles

About Article Author